363 results match your criteria: "Nevus Sebaceus"
Arch Dermatol Res
June 2024
Department of Dermatology, SUNY Downstate, 450 Clarkson Ave, Brooklyn, NY, USA.
JAAD Case Rep
June 2024
Department of Dermatology and Allergy, Technische Universität München, Munich, Germany.
Asian J Surg
August 2024
Hospital for Skin Diseases, Shandong First Medical University, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, China. Electronic address:
Indian J Dermatol
January 2023
From the Department of Surgical Oncology, Government Medical College, Kottayam, Kerala, India.
Indian J Dermatol Venereol Leprol
August 2023
Department of Dermatology, Command Hospital Air Force, Bangalore, India.
Ann Dermatol
May 2023
Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Korea.
Cutis
May 2023
Dr. Fernandes is from the San Antonio Uniformed Services Health Education Consortium, Lackland Air Force Base, Texas. Dr. Sang is from US Naval Hospital Yokosuka, Japan. Dr. Sperling is from Walter Reed National Military Medical Center, Bethesda, Maryland. Dr. Sperling also is from the Uniformed Services University of the Health Sciences, Bethesda.
Skin Res Technol
June 2023
Department of Dermatology, University of Illinois-Chicago, Chicago, Illinois, USA.
Introduction: Phacomatosis pigmentokeratotica (PPK), an epidermal nevus syndrome, is characterized by the coexistence of nevus spilus and nevus sebaceus. Within the nevus spilus, an extensive range of atypical nevi of different morphologies may manifest. Pigmented lesions may fulfill the ABCDE criteria for melanoma, which may prompt a physician to perform a full-thickness biopsy.
View Article and Find Full Text PDFJ Cutan Pathol
September 2023
MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
Arch Pathol Lab Med
February 2024
From the Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (Cornejo, Nazarian).
Context.—: Syringocystadenocarcinoma papilliferum (SCACP) is a rare adnexal carcinoma and the malignant counterpart of syringocystadenoma papilliferum (SCAP), which is commonly located on the head and neck and may arise in association with a nevus sebaceus. RAS mutations have been identified in both SCAP and nevus sebaceus.
View Article and Find Full Text PDFDermatologie (Heidelb)
May 2023
Universitäts-Hautklinik, Hauptstr. 7, 79104, Freiburg, Deutschland.
Am J Dermatopathol
March 2023
Benchmark Diagnostics, LLC, Middleburg Heights, OH.
Clin Cosmet Investig Dermatol
December 2022
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia.
Cureus
October 2022
Department of Medicine, Division of Dermatology, University of Vermont Medical Center, Burlington, USA.
J Cutan Pathol
March 2023
Department of Dermatology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Cureus
August 2022
Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, USA.
J Cutan Pathol
April 2023
Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
J Dtsch Dermatol Ges
September 2022
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine (dEBM), Berlin.
Diagnostics (Basel)
June 2022
Department of Dermatology, International University of Health and Welfare, Narita 286-8520, Chiba, Japan.
Nevus sebaceus is a benign tumor that is present at birth and is often seen on the scalp or face. Secondary malignant tumors sometimes occur in nevus sebaceus in adulthood. Herein, we present two malignant tumors arose from nevus sebaceus.
View Article and Find Full Text PDF